DiaSafe™: Fast AI-based decision support system for diabetic foot ulcer (DFU) detection
* DiaSafe is not yet available for commercial use.
Safe, real-time optical readings of biomarkers
By sensing the invisible, DiaSafe™, IR-MED’s newest handheld device, is being designed to non-invasively analyze the biomarkers of blood and tissue, at the point of care, to help healthcare providers prevent diabetic foot ulcers from developing in their diabetic patients.
Early detection can reduce healthcare costs, save limbs, and save lives.
- More cost effective to manage in initial stages.1
- Detecting and treating early DFU can significantly improve quality of life by reducing pain and mobility issues.2
- Early intervention can reduce death rate associated with diabetic foot complications.3
- Diabetic foot ulcers are the most common cause of amputation and a $10.5 billion global treatment market expected to grow to $17.7 billion by 2031.4
References :
1 ClinicoEconomics and Outcomes Research 2Frontiers in Endochronology 3Journal of Public Health Research 4Transparency Markets and Research
